These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors. Nguyen CT; Stephenson AJ Hematol Oncol Clin North Am; 2011 Jun; 25(3):593-604, ix. PubMed ID: 21570611 [TBL] [Abstract][Full Text] [Related]
25. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia. Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765 [TBL] [Abstract][Full Text] [Related]
26. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection. Svatek RS; Spiess PE; Sundi D; Tu SM; Tannir NM; Brown GA; Kamat AM; Wood CG; Pisters LL Cancer; 2009 Mar; 115(6):1310-7. PubMed ID: 19156903 [TBL] [Abstract][Full Text] [Related]
39. Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data. Williams SB; McDermott DW; Winston D; Bahnson E; Berry AM; Steele GS; Richie JP BJU Int; 2010 Apr; 105(7):918-21. PubMed ID: 19747353 [TBL] [Abstract][Full Text] [Related]
40. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]